View in EDS HTML Full Text PDF Full Text

Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.

Saved in:
Bibliographic Details
Title: Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
Authors: Horn B; Quince Therapeutics, Inc., South San Francisco, CA, United States., Mambrini G; Quince Therapeutics, Inc., South San Francisco, CA, United States., Roden M; Quince Therapeutics, Inc., South San Francisco, CA, United States., Schaefer C; Quince Therapeutics, Inc., South San Francisco, CA, United States., Thye D; Quince Therapeutics, Inc., South San Francisco, CA, United States., Magnani M; Department of Biomolecular Sciences, University of Urbino, Urbino, Italy.
Source: Frontiers in drug delivery [Front Drug Deliv] 2025 Dec 08; Vol. 5, pp. 1730142. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918469589006676 Publication Model: eCollection Cited Medium: Internet ISSN: 2674-0850 (Electronic) Linking ISSN: 26740850 NLM ISO Abbreviation: Front Drug Deliv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41438155
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Horn+B%22">Horn B</searchLink>; Quince Therapeutics, Inc., South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Mambrini+G%22">Mambrini G</searchLink>; Quince Therapeutics, Inc., South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Roden+M%22">Roden M</searchLink>; Quince Therapeutics, Inc., South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Schaefer+C%22">Schaefer C</searchLink>; Quince Therapeutics, Inc., South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Thye+D%22">Thye D</searchLink>; Quince Therapeutics, Inc., South San Francisco, CA, United States.<br /><searchLink fieldCode="AU" term="%22Magnani+M%22">Magnani M</searchLink>; Department of Biomolecular Sciences, University of Urbino, Urbino, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918469589006676%22">Frontiers in drug delivery</searchLink> [Front Drug Deliv] 2025 Dec 08; Vol. 5, pp. 1730142. <i>Date of Electronic Publication: </i>2025 Dec 08 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918469589006676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2674-0850 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226740850%22">26740850 </searchLink><i>NLM ISO Abbreviation: </i>Front Drug Deliv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41438155
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fddev.2025.1730142
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1730142
    Titles:
      – TitleFull: Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Horn B
      – PersonEntity:
          Name:
            NameFull: Mambrini G
      – PersonEntity:
          Name:
            NameFull: Roden M
      – PersonEntity:
          Name:
            NameFull: Schaefer C
      – PersonEntity:
          Name:
            NameFull: Thye D
      – PersonEntity:
          Name:
            NameFull: Magnani M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 12
              Text: 2025 Dec 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2674-0850
          Numbering:
            – Type: volume
              Value: 5
          Titles:
            – TitleFull: Frontiers in drug delivery
              Type: main
ResultId 1